Several studies [36–39] have shown a strong correlation between the presence of BRAF mutation and lymph node metastasis, extrathyroid extension [40], advanced stage (III and IV) on diagnosis, and disease recurrence. The gene discussed is BRAF; the disease is metastatic malignant neoplasm in the lymph nodes.